Noroxin Related Published Studies
Well-designed clinical trials related to Noroxin (Norfloxacin)
Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial. [2010.12]
Norfloxacin Therapy for Hepatopulmonary Syndrome: A Pilot Randomized Controlled Trial. [2010.08.31]
Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. [2009.11]
Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial. [2009.03]
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. [2006.10]
Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection. [2006.04]
Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis. [2005.10]
Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. [2005.04]
The influence of norfloxacin and metronidazole on the disposition of mycophenolate mofetil. [2005.02]
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. [2004.10]
Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. [2003.09.01]
[Treatment of bacterial conjuntivitis with topical ciprofloxacin and norfloxacin: a comparative study] [2003.03]
Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection. [2002.10]
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. [2002.06]
Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. [2002.01]
Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. [2002]
Pulse and continuous oral norfloxacin treatment of experimentally induced Escherichia coli infection in broiler chicks and turkey poults. [2002]
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. [2001]
Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin and Noroxin) in healthy human volunteers. [2000.07]
Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial. [2000.01]
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children. [1999.12]
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding. [1998.12]
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. [1998.09]
Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. [1998.04]
Comparison of the efficacy of tetracycline and norfloxacin in the treatment of acute severe watery diarrhea. [1998.03]
A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer. [1998.02]
Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study. [1997.07]
Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. [1997.06]
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. [1997.03]
Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. [1997.03]
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. [1997.03]
[Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin] [1997.01]
A double-blind comparative study of norfloxacin versus placebo in hospitalised elderly patients with asymptomatic bacteriuria. [1996.09]
Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions. [1996.07]
Efficacy of norfloxacin and doxycycline for treatment of vibrio cholerae 0139 infection. [1996.03]
Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations. [1996.02]
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. [1996.01]
Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study. [1996]
Comparison of rufloxacin and norfloxacin effects on faecal flora. [1995.06]
Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients. [1995.05]
Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections. [1995]
Lack of effect of preoperative norfloxacin on bacterial contamination of anterior chamber aspirates after cataract surgery. [1994.10]
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. [1994.08.27]
Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt. [1994.08]
Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora. [1994.07]
Effect of sucralfate on absorption of norfloxacin and ofloxacin. [1994.02]
The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin. [1994.01]
Effect of milk on absorption of norfloxacin in healthy volunteers. [1993.12]
Norfloxacin as prophylaxis against urethral strictures following transurethral resection of the prostate: an open, prospective, randomized study. [1993.11]
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. [1993.10]
Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B. [1993.09]
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections. [1993.05]
Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study. [1993.03.22]
Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. [1993.03.22]
Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection. [1993.03.22]
Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin. [1993.03]
Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. [1993.03]
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. [1993.03]
[Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days] [1993.02.27]
[Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections] [1992.12]
Efficacy and tolerability of norfloxacin vs. ciprofloxacin in complicated urinary tract infection. [1992.11]
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. [1992.10]
Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial. [1992.09]
Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. [1992.08.01]
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis. [1992.06.22]
Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group. [1992.06.15]
[A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study] [1992.06]
Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group. [1992.06]
Norfloxacin is inferior to chloroquine for falciparum malaria in northwestern Zambia: a comparative clinical trial. [1992.05]
Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults. [1992.04.06]
Norfloxacin prophylaxis for endoscopic urological surgery. [1992.04]
The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group. [1992.04]
Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa. [1992.02]
Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin. [1992]
The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. [1992]
Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. [1992]
Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients. [1992]
Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections. [1991.12.30]
Randomized clinical trial of norfloxacin for shigellosis. [1991.12]
Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women. [1991.10]
Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin or chloramphenicol. [1991.09]
Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection. [1991.06]
Cefodizime (HR221) versus norfloxacin for treatment of urinary tract infections. [1991.02]
Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections. [1991]
Single-dose pefloxacin versus five-days treatment with norfloxacin in uncomplicated cystitis in women. [1990.10]
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. [1990.10]
Norfloxacin does not alter warfarin's disposition or anticoagulant effect. [1990.08]
Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study. [1990.05]
Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. [1990.05]
Double-blind, randomized, controlled clinical trial of norfloxacin for cholera. [1990.05]
[A clinical study on the use of norfloxacin in the therapy of urethritis caused by Chlamydia trachomatis] [1990.04]
Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole. [1990.02]
Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel. [1990.02]
Norfloxacin vs. pivmecillinam in the treatment of uncomplicated lower urinary tract infections in hospitalized elderly patients. [1990]
Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections. [1990]
Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly. [1990]
Fosfomycin trometamol (Monuril) versus norfloxacin in single dose for adult female uncomplicated UTIs. Multicenter randomized, double-blind study. [1990]
Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. [1990]
Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice. [1990]
Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients. [1989.10]
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. [1989.07]
|